Answer
Diarrhoea during tucatinib treatment has been reported with severe complications including dehydration, hypotension, acute kidney injury and death.
Sources for this answer
- TUKYSA 50 mg film-coated tabletPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 5Document updated
Sources checked